ID

11995

Description

Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01649050

Lien

https://clinicaltrials.gov/show/NCT01649050

Mots-clés

  1. 30/08/2015 30/08/2015 -
Téléchargé le

30 août 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Diagnosis of multiple sclerosis (MS) of any type.
Description

Diagnosis of multiple sclerosis (MS) of any type.

Type de données

boolean

Alias
UMLS CUI [1]
C0026769
UMLS CUI [2]
C0332307
MS diagnosis at least 6 months prior to screening.
Description

MS diagnosis at least 6 months prior to screening.

Type de données

boolean

Alias
UMLS CUI [1]
C0011900
UMLS CUI [2]
C0026769
Stable MS with no relapse within 3 months prior to screening.
Description

Stable MS with no relapse within 3 months prior to screening.

Type de données

boolean

Alias
UMLS CUI [1]
C0035020
Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.
Description

Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.

Type de données

boolean

Alias
UMLS CUI [1]
C0026838
UMLS CUI [2]
C0026769
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Patients with symptoms of spasticity not due to MS.
Description

Patients with symptoms of spasticity not due to MS.

Type de données

boolean

Alias
UMLS CUI [1]
C0026838
Patients taking three or more different anti-spasticity medications.
Description

Patients taking three or more different anti-spasticity medications.

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
UMLS CUI [2]
C0026838
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
Description

Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.

Type de données

boolean

Alias
UMLS CUI [1]
C0235874
UMLS CUI [2]
C0026769
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
Description

Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.

Type de données

boolean

Alias
UMLS CUI [1]
C0015980
Use of baclofen pump at any time.
Description

Use of baclofen pump at any time.

Type de données

boolean

Alias
UMLS CUI [1]
C3836732
Wheelchair or bed-bound patients.
Description

Wheelchair or bed-bound patients.

Type de données

boolean

Alias
UMLS CUI [1]
C0043143

Similar models

Eligibility Muscle Spasticity Due to Multiple Sclerosis NCT01649050

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
multiple sclerosis; type
Item
Diagnosis of multiple sclerosis (MS) of any type.
boolean
C0026769 (UMLS CUI [1])
C0332307 (UMLS CUI [2])
diagnosis; multiple sclerosis
Item
MS diagnosis at least 6 months prior to screening.
boolean
C0011900 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
relapse
Item
Stable MS with no relapse within 3 months prior to screening.
boolean
C0035020 (UMLS CUI [1])
spasticity; multiple sclerosis
Item
Treated or untreated spasticity due to MS for at least 3 months prior to screening, not wholly relieved with antispasticity medications.
boolean
C0026838 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
spasticity
Item
Patients with symptoms of spasticity not due to MS.
boolean
C0026838 (UMLS CUI [1])
medications; spasticity
Item
Patients taking three or more different anti-spasticity medications.
boolean
C0013227 (UMLS CUI [1])
C0026838 (UMLS CUI [2])
Disease Exacerbation; multiple sclerosis
Item
Acute MS exacerbation requiring treatment within 3 months of the Screening Visit.
boolean
C0235874 (UMLS CUI [1])
C0026769 (UMLS CUI [2])
interferon beta
Item
Initiation of, or the discontinuation of interferon beta or any other disease modifying therapy for MS within 3 months of the Screening Visit.
boolean
C0015980 (UMLS CUI [1])
baclofen pump
Item
Use of baclofen pump at any time.
boolean
C3836732 (UMLS CUI [1])
wheelchair
Item
Wheelchair or bed-bound patients.
boolean
C0043143 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial